Ginger is a low-cost, well-tolerated root with modest but real effects. Its strongest benefit is easing nausea and vomiting. Good evidence supports lower inflammation and small reductions in blood pressure, joint pain, and menstrual pain; effects on blood sugar and cholesterol are mixed. Broader longevity claims remain unproven. Main cautions: mild stomach upset and additive effects with blood thinners. (Full Review)
| Marker | Target | Why |
|---|---|---|
| High-sensitivity C-reactive protein (hs-CRP) | < 1.0 mg/L (ideally < 0.5) | Tracks the inflammation ginger is expected to lower |
| Fasting blood glucose (FBS) | 70–85 mg/dL | Detects additive glucose lowering and metabolic benefit |
| Glycated hemoglobin (HbA1c) | < 5.3% | Reflects average blood sugar over ~3 months |
| Blood pressure | ~110–120 / 70–75 mmHg | Captures ginger's mild blood-pressure effect and additive risk with drugs |
| Triglycerides | < 80 mg/dL | Monitors lipid effects, which are variable |
| HDL cholesterol | > 55 mg/dL (women), > 45 (men) | Ginger may modestly raise this protective cholesterol |
| Alanine aminotransferase (ALT) | < 25 U/L (men), < 20 (women) | Tracks liver health where fatty liver is a target |
| International normalized ratio (INR) | Individualized (e.g., 2.0–3.0 on warfarin) | Essential safety check when combining ginger with warfarin |
Cadence: Baseline, then about 8–12 weeks after starting, and thereafter every 6–12 months; INR within 1–2 weeks of starting for those on interacting medications